| 
Citations
 | 
   web
Anbalagan, M., Dauchy, R., Xiang, S., Robling, A., Blask, D., Rowan, B., et al. (2019). SAT-337 Disruption Of The Circadian Melatonin Signal By Dim Light At Night Promotes Bone-lytic Breast Cancer Metastases. Journal of the Endocrine Society, 3(Supplement_1).
toggle visibility
Dauchy, R. T., Xiang, S., Mao, L., Brimer, S., Wren, M. A., Yuan, L., et al. (2014). Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res, 74(15), 4099–4110.
toggle visibility
deHaro, D., Kines, K. J., Sokolowski, M., Dauchy, R. T., Streva, V. A., Hill, S. M., et al. (2014). Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night. Nucleic Acids Res, 42(12), 7694–7707.
toggle visibility
Hanifin, J. P., Dauchy, R. T., Blask, D. E., Hill, S. M., & Brainard, G. C. (2020). Relevance of Electrical Light on Circadian, Neuroendocrine, and Neurobehavioral Regulation in Laboratory Animal Facilities. ILAR Journal, in press.
toggle visibility
Mason, I. C., Boubekri, M., Figueiro, M. G., Hasler, B. P., Hattar, S., Hill, S. M., et al. (2018). Circadian Health and Light: A Report on the National Heart, Lung, and Blood Institute's Workshop. J Biol Rhythms, 33(5), 451–457.
toggle visibility
Xiang, S., Dauchy, R. T., Hoffman, A. E., Pointer, D., Frasch, T., Blask, D. E., et al. (2019). Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer. J Pineal Res, 67(2), e12586.
toggle visibility